Skip to main content
SpringerLink
Log in

The Main Events in the History of Diabetes Mellitus

  • Reference work entry
  • First Online:
Book cover Principles of Diabetes Mellitus

Abstract

A medical condition producing excessive thirst, continuous urination, and severe weight loss has interested medical authors for over three millennia. Unfortunately, until the early part of the twentieth century the prognosis for a patient with this condition was no better than it was over 3000 years ago. Since the ancient physicians described almost exclusively cases of what is known today as type 1 diabetes mellitus, the outcome was invariably fatal.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Papaspyros NS. The history of diabetes. In: Verlag GT, editor. The history of diabetes mellitus. Stuttgart: Thieme; 1964. p. 4.

    Google Scholar 

  2. http://www.crystalinks.com/egyptmedicine.html – ancient Egyptian medicine, Ebers papyrus.

  3. Medvei VC. The Greco – Roman period. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 34–7.

    Google Scholar 

  4. Southgate TM. De medicina. JAMA. 1999;10:921.

    Google Scholar 

  5. Sanders LJ. From Thebes to Toronto and the 21st century: an incredible journey. Diabetes Spect. 2002;15:56–60.

    Article  Google Scholar 

  6. Medvei VC. Mediaeval scene. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 46–9.

    Google Scholar 

  7. Medvei VC. The 16th century and the renaissance. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 55–6.

    Google Scholar 

  8. Medvei VC. The 18th century and the beginning of the 19th century. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest Times to the present day. New York: Parthenon Publishing; 1993. p. 97.

    Google Scholar 

  9. www.uic.edu – Claude Bernard.

  10. www.britannica.com – Claude Bernard.

  11. Medvei VC. Story of insulin. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 249–51.

    Google Scholar 

  12. Schullian DM. John Rollo’s patient. J Hist Med. 1965;2:163–4.

    Google Scholar 

  13. Bliss M. A long prelude. In: Bliss M, editor. The discovery of insulin. Chicago: The University of Chicago Press; 1982. p. 33–9.

    Google Scholar 

  14. Minkowski O. Introduction and translation by R. Levine. Historical development of the theory of pancreatic diabetes. Diabetes. 1989;38:1–6.

    Article  CAS  PubMed  Google Scholar 

  15. Medvei VC. The birth of endocrinology. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 151.

    Google Scholar 

  16. Bliss M. Banting’s idea. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 2007. p. 45–58.

    Google Scholar 

  17. Bliss M. A mysterious something. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 2007. p. 84–103.

    Google Scholar 

  18. Bliss M. Triumph. In: Bliss M, editor. The discovery of insulin. Chicago: University of Chicago Press; 1982. p. 104–28.

    Chapter  Google Scholar 

  19. MacCracken J. From ants to analogues. Puzzles and promises in diabetes management. Postgrad Med. 1997;4:138–50.

    Article  Google Scholar 

  20. Pratt P. History of insulin. Hutchinson family encyclopedia. Online edition. Oxford: Helicon Publishing; 2000.

    Google Scholar 

  21. Born DM. The journey and the dream: a history of the American Diabetes Association. Alexandria: American Diabetes Association; 1990. p. 1–14.

    Google Scholar 

  22. www.nobel.se – August Krogh.

  23. Medvei VC. Present trends and outlook for the future – part III. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 380–3.

    Google Scholar 

  24. http://web.mit.edu/invent/iow/yalow.html

  25. Segre GV, Brown EN. Measurement of hormones. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders; 1998. p. 44–5.

    Google Scholar 

  26. Medvei VC. Chronological tables. In: Medvei VC, editor. The history of clinical endocrinology: a comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing; 1993. p. 495.

    Google Scholar 

  27. www.gene.com – press release 6 Sept 1978.

  28. Galloway J, DeShazo R. Insulin chemistry and pharmacology: insulin allergy, resistance, and lipodystrophy. In: Rifkin H, Porte Jr D, editors. Diabetes mellitus. Theory and practice. 4th ed. New York: Elsevier; 1990. p. 498.

    Google Scholar 

  29. https://www.afrezzapro.com/

  30. http://www.mendosa.com/history.htm

  31. Blevins TC, et al. Statement by the American Association of Clinical Endocrinologists Consensus panel on continuous glucose monitoring. Endocr Pract. 2010;16(5):730–45.

    Article  PubMed  Google Scholar 

  32. Holmquist WR, Schroeder WA. A new N-terminal blocking group involving a Schiff base in hemoglobin A1c. Biochemistry. 1966;5:2489–503.

    Article  CAS  PubMed  Google Scholar 

  33. Bookchin RM, Gallop PM. Structure of hemoglobin A1c: nature of the N-terminal β chain blocking group. Biochem Biophys Res Commun. 1968;32:86–93.

    Article  CAS  PubMed  Google Scholar 

  34. Samuel R. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta. 1968;22:296–8.

    Article  Google Scholar 

  35. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969;36:838–43.

    Article  CAS  PubMed  Google Scholar 

  36. Tattersall RB, Pyke DA, Ranney HM, Bruckheimer SM. Hemoglobin components in diabetes mellitus: studies in identical twins. N Engl J Med. 1975;293:1171–3.

    Article  CAS  PubMed  Google Scholar 

  37. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cermani A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976;295:417–20.

    Article  CAS  PubMed  Google Scholar 

  38. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  39. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.

    Article  PubMed Central  Google Scholar 

  40. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.

    Article  Google Scholar 

  41. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

    Article  Google Scholar 

  42. UK Prospective Diabetes Study Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412–9.

    Article  Google Scholar 

  43. UK Prospective Diabetes Study Group. Effects of intensive blood-glucose control with metformin on complications in overweight patients with type 2 Diabetes (UKPDS 34). Lancet. 1998;325:854–65.

    Google Scholar 

  44. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. NIH: National Heart, Lung, and Blood. Updated March 14, 2010. https://www.nhlbi.nih.gov/health-pro/resources/heart/accord-trial. Accessed 26 Sept 2015.

  45. The Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14:737–52.

    Article  PubMed Central  Google Scholar 

  46. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes: the Look AHEAD Research Group. N Engl J Med. 2013. doi: 10.1056/NEJMoa1212914.

    Google Scholar 

  47. Gruessner RWG, Sutherland D, Kandaswamy R, et al. Lessons learned from >500 pancreas transplants alone at a single institution. Am J Transplant. 2007;7:249.

    Article  Google Scholar 

  48. Lacy PE, Kostianovsky M. Methods for the isolation of intact islets of Langerhans from rat pancreas. Diabetes. 1967;16:35–9.

    Article  CAS  PubMed  Google Scholar 

  49. Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet cell transplant to prevent diabetes after pancreatic resection. Ann Surg. 1995;222:562–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Shapiro JAM, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–8.

    Article  CAS  PubMed  Google Scholar 

  51. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–8.

    Article  CAS  PubMed  Google Scholar 

  52. Matsumoto S. Clinical allogeneic and autologous islet cell transplantation: update. Diabetes Metab J. 2011;35(3):199–206. doi:10.4093/dmj.2011.35.3.199.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Artificial Pancreas Project Research: Artificial Pancreas Project Plan. Juvenile Diabetes Research Foundation. JDRF 2015. http://jdrf.org/research/treat/artificial-pancreas-project/. Accessed 23 Aug 2015.

  54. Clinical Studies and the Development of the Artificial Pancreas. U.S. Food and Drug Administration. U.S. Department of Health and Human Sevices. 2014. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/ConsumerProducts/ArtificialPancreas/ucm259568.htm. Accessed 23 Aug 2015

  55. Russell SJ, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313–25. doi: 10.1056/NEJMoa1314474.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Overweight and obesity statistics. National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Department of Health and Human Services. Updated Oct 2012. http://www.niddk.nih.gov/health-information/health-statistics/Pages/overweight-obesity-statistics.aspx. Accessed 26 Sept 2015.

  57. Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38:1567–82. doi:10.2337/dc15-1081.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Morbidity and Mortality Weekly Report. Center of diabetes control and prevention. MMWR. 2004;53:80–2.

    Google Scholar 

  59. Manson JE, Rimm EB, Stampfer MJ, et al. A prospective study of physical activity and incidence of non insulin-dependent diabetes mellitus in women. Lancet. 1991;338:774–7.

    Article  CAS  PubMed  Google Scholar 

  60. U.S. Department of Health and Human Services. Healthy people 2000: summary report. Washington, DC: U.S. Department of Health and Human Services (DHHS Publ. PHSSs 91–50213); 1992. p. 6–8, 55, 91–2.

    Google Scholar 

  61. Tuomilehto J, Lindstrom J, Eriksson JG, Finnish Diabetes Prevention Study Group, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  PubMed  Google Scholar 

  62. Pan XR, Li GW, Wang JX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.

    Article  CAS  PubMed  Google Scholar 

  63. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325:147–52.

    Article  CAS  PubMed  Google Scholar 

  64. www.niddk.nih.gov – results of Diabetes Prevention Program, Diabetes Prevention Trial.

  65. Diabetes Prevention Trial – Type 1 Diabetes Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002;346:1685–91.

    Article  Google Scholar 

  66. Diabetes Prevention Trial – Type 1 Diabetes Group. Effects of oral insulin in relatives of patients with type 1 diabetes. Diabetes Care. 2005;28:1068–76.

    Article  Google Scholar 

  67. Fowler, G. Dr. Ora M. Rosen, 55, scientist: studied the development of cells. The New York Times. 1 June 1990.

    Google Scholar 

  68. Rosen OM. After insulin binds. Science. 1987;237:1452–8. doi:10.1126/science.2442814.

    Article  CAS  PubMed  Google Scholar 

  69. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.

    Article  CAS  PubMed  Google Scholar 

  71. Zeggini E, Weedon MN, Lindgren CM, McCarthy MI, Hattersley AT. Replications of genome wide association signals in UIC sample reval risk loci for type Z diabetes. The Welcome Trust Case Control Consortium (WTCCC), et al. Science. 2007;316:1336–41.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, New York, NY, USA

    Rachel Goldman

  2. Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, New York, NY, USA

    Jacek Zajac, Anil Shrestha & Parini Patel

  3. Division of Endocrinology, Diabetes and Metabolism, Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, New York, NY, USA

    Leonid Poretsky

  4. Division of Endocrinology and Metabolism, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Leonid Poretsky

Authors
  1. Rachel Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacek Zajac
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anil Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parini Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leonid Poretsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonid Poretsky .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, New York, New York, USA

    Leonid Poretsky

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Goldman, R., Zajac, J., Shrestha, A., Patel, P., Poretsky, L. (2017). The Main Events in the History of Diabetes Mellitus. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Cham. https://doi.org/10.1007/978-3-319-18741-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18741-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18740-2

  • Online ISBN: 978-3-319-18741-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation